Suicide Risk Prevention Among Patients With Anxiety Psychopathology
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Anxiety
- Sponsor
- Florida State University
- Enrollment
- 74
- Locations
- 1
- Primary Endpoint
- Anxiety Sensitivity Index-3 (ASI-3)
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to test the effectiveness and usability of multiple computer-based treatments for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with a variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal ideation, and substance use disorders.
Detailed Description
CATS is a newly developed computerized treatment targeting specific risk factors associated with anxiety symptoms and suicidal thoughts. Individuals will be asked to complete four appointments, where they will complete various self-report questionnaires as well as a newly developed computerized treatment targeting risk factors associated with anxiety.
Investigators
Norman Schmidt
Distinguished Professor
Florida State University
Eligibility Criteria
Inclusion Criteria
- •Meet diagnostic criteria for a primary Axis 1 anxiety disorder or meet diagnostic criteria for a unipolar mood disorder along with an Axis 1 anxiety disorder.
- •Show evidence of current suicidal ideation (BSS above
- •Show elevated AS indicated by scoring at or above the community sample mean on the ASI-Cog (above 9.
Exclusion Criteria
- •No significant medical illness (e.g. sig cardiovascular disease, epilepsy, stroke).
- •Current or past psychotic-spectrum disorders or uncontrolled bipolar disorder
- •No current substance dependence
- •Must be an English speaker.
- •Must be 18 years or older.
- •Must have normal or corrected vision
- •Cannot begin treatment/therapy within 1 month of baseline.
- •Cannot begin a new medication within 3 months of baseline.
Outcomes
Primary Outcomes
Anxiety Sensitivity Index-3 (ASI-3)
Time Frame: Month 4 follow-up
The ASI-3 is an 18-item self-report measure of anxiety sensitivity (AS). This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the original ASI provides. Each subfactor is represented by six items. The measure has shown good psychometric properties.
Secondary Outcomes
- Beck Suicide Scale (BSS)(Month 4 follow-up)